The CHICAGO Trial is a program dedicated to eliminating asthma health disparities. Asthma is one of the most common chronic conditions nationwide, and is a leading source of morbidity for children. Racial and ethnic disparities are especially important in asthma, with African American and inner-city children being disproportionately affected.

The CHICAGO Trial is a collaborative effort between 13 Chicago based institutions, led by the University of Illinois Hospital & Sciences System. Collaborating institutions include the Sinai Health System, Rush University Medical Center, Lurie Children's Hospital, University of Chicago, Northwestern University, Chicago Department of Public Health, Respiratory Health Association, Chicago Asthma Consortium, NorthShore University Health System, and the Illinois Institute of Technology. Drawing on collaborations that span nearly two decades, we propose studies testing both provider- and patient-level interventions to improve clinically meaningful outcomes in a minority pediatric ED population with uncontrolled asthma.

The CHICAGO Trial is funded by the Patient Centered Outcomes Research Institute (PCORI); contract # AS-1307-05420. Link to funding announcement: http://pfaawards.pcori.org/node/20/datavizwiz/detail/5420